We Take Diagnostics to the Next Level

At Ares Genetics, we develop precision diagnostics for precision medicine to improve the way infections are diagnosed and treated.

We Take Diagnostics to the Next Level

At Ares Genetics, we develop precision diagnostics for precision medicine to improve the way infections are diagnosed and treated.

News

18/2/2019

Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance

Download

8/1/2019

Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test

Download

18/12/2018

Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance

Download

Latest tweets

Events

Meet the Ares Team at the following events

13/04/2019

Amsterdam, Netherlands

European Conference on Clinical Microbiology

Go To Event Page

25/03/2019

Vienna, Austria

BIO-Europe Spring

Go To Event Page

Career

We are data scientists, bioinformaticians, microbiologists, pharmaceutical, diagnostic and commercial experts that share a vision for the next-generation of genomics-based infectious disease diagnostics & therapeutics.

Join us in taking infectious disease diagnostics to the next level!

Besides the openings listed below, we are regularly offering part- or full-time positions as well as PhD and master theses and welcome unsolicitated applications.

Technical Assistant Clinical Microbiology & Molecular Diagnostics (m/f)

für ein unbefristetes Dienstverhältnis in Vollzeit.

Laboratory Quality & Regulatory Manager (QA/RA) (m/f)

for a staff function role in full-time employment.

Molecular Diagnostics Expert (m/f)

for a staff function role in unlimited full-time employment.

Press Kit

No items found.

Publications

At Ares, we pursue a partnership based, open-innovation approach with academic and industry partners and are committed to sharing our developments with the community.

Scientific Publications & Application Notes

Optimizing plasmid identification for clinical bacterial Isolates using Next-Generation Sequencing

Joint publication with Prof. Keller’s group at Saarland University assessing the heterogeneity of in silico plasmid predictions based on whole-genome-sequenced clinical isolates. The study identified a high degree of heterogeneity and variation in sensitivity and precision for plasmid identification across taxa and computational approaches. Nevertheless, existing open source tools are very valuable for investigating the plasmid-borne resistome. Building upon the peer-reviewed research findings, the proprietary ARES Technology allows for fast and optimized plasmid identification from whole-genome sequencing data.

GEAR-base: The GEnetic Antibiotic Resistance & Susceptibility Database

Joint publication with Prof. Keller's Group Keller’s group at Saarland University introducing GEAR-base as a standardized research resource for antibiotic resistance genotypes and phenotypes. GEAR-base builds on Ares’ proprietary collection of pathogen genomes and resistance profiles and we invite you to join us to further advance antibiotic resistance research. Please sign up at https://gear-base.com or contact us at contact@ares-genetics.com and you will receive an invitation to join GEAR-base for academic research use upon publication of the accompanying manuscript (currently under review).

Ares Genetics and Curetis Pharma Services

We offer a comprehensive portfolio of solutions for antimicrobial drug discovery, clinical development, and product lifecycle management. Our solutions aim at supporting data-driven target and lead prioritization, accelerating clinical trials, augmenting clinical data for regulatory submissions, and informed antimicrobial drug use for effective antibiotic stewardship post launch.

Fast and accurate taxonomic Identification of clinical bacterial Isolates using Next-Generation Sequencing

Joint publication with Prof. Keller’s group at Saarland University comparing genome versus proteome-based identification of clinical bacterial isolates. Key findings include that taxonomic identification based on the proteome (by mass spectrometry, MS-biotyping) and the genome (by next-generation sequencing, NGS) show high concordance for clinical application. While NGS successfully resolved all clinical isolates on the species level, for 12% of the cases MS-biotyping resulted in genus level classification only. Building upon the peer-reviewed research findings, ARES Technology allows for fast and accurate taxonomic identification on the species level.